Rhythm Pharmaceuticals

human brain abstract art
Pharma

Rhythm's Imcivree bags FDA nod for brain-damage related obesity

The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired hypothalamic obesity.
Zoey Becker Mar 20, 2026 11:05am
Darts failing to hit bullseye

Rhythm's Imcivree posts ph. 3 miss in rare genetic obesities

Mar 17, 2026 11:43am
FDA Building

Rhythm scores first FDA nod for rare genetic-defect obesity med

Nov 30, 2020 3:37am